FDA Approves groundbreaking drug for schizophrenia treatment
On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.
Cobenfy: The First New Schizophrenia Drug in Decades
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
Sydney Morning Herald5m
The Australian research (and brains) that led to a new schizophrenia drug
The FDA has approved the first new class of schizophrenia drug in 70 years Australian science contributed to the discovery of ...
India Today on MSN58m
US FDA approves new schizophrenia drug
The US FDA has approved a new drug, Cobenfy, for treating schizophrenia in adults. This is a first new class for medication ...
FDA approves PureTech’s KarXT to treat schizophrenia in adults
PureTech Health has obtained approval from the US Food and Drug Administration (FDA) for KarXT to treat schizophrenia in ...
Valley News Live13h
FDA approves new drug for schizophrenia, described as a potential ‘game changer’
FARGO, N.D. (Valley News Live) - Changes are coming to the way schizophrenia is treated. The US Food and Drug Administration ...
Experts hail new schizophrenia drug Cobenfy as a game-changer, the ‘first of its kind’
Cobenfy is the first schizophrenia drug in decades to treat the mental health condition in a new way, with potentially fewer ...
ScienceAlert8h
First New Schizophrenia Treatment in Decades a Much-Needed Alternative
Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...
Medscape20h
Clozapine and Respiratory Infection Risk: What to Know
Recent research is painting a clearer picture of the link between the use of clozapine for schizophrenia and respiratory ...
MyChesCo on MSN7h
FDA Approves Cobenfy, Pioneering New Approach to Schizophrenia Treatment
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of ...
McKnight's Long-Term Care News6h
Schizophrenia treatment offers alternative with fewer side effects
The Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), making it the first major ...
FDA approves new drug for treatment of schizophrenia
The U.S. Food and Drug Administration approved a new drug for the treatment of schizophrenia in adults. Dr. Darien Sutton explains.